Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 2, 2011, Pages 448-454

  Sillesen, Martin ^a,b   Hjortdal, Vibeke ^a   Vejlstrup, Niels ^b   Sørensen, Keld ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Anticoagulation; Embryopathy; Heart valves; Pregnancy

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; BRAIN ISCHEMIA; CAUSE OF DEATH; CESAREAN SECTION; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYOPATHY; FEMALE; FETUS WASTAGE; GESTATIONAL AGE; GROWTH RETARDATION; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; NEWBORN DEATH; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SPONTANEOUS ABORTION; STROKE; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; CONGENITAL ABNORMALITIES; DENMARK; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; INFANT, NEWBORN; MATERNAL MORTALITY; MITRAL VALVE; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; PROGNOSIS; PROSTHESIS DESIGN; REGISTRIES; YOUNG ADULT;

EID: 79960276215     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.12.011     Document Type: Article

References (25)

1. Sbarouni E., Oakley C.M. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994, 71(2):196-201.
2. Elkayam U., Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol 2005, 46(3):403-410.
3. Elkayam U. Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999, 33(6):1642-1645.
4. Marsal K., Persson P.H., Larsen T., Lilja H., Selbing A., Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996, 85(7):843-848.
5. Beierlein W., Becker V., Yates R., Tsang V., Elliott M., de L.M., van D.C. Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardiothorac Surg 2007, 31(5):860-865.
6. Geelani M.A., Singh S., Verma A., Nagesh A., Betigeri V., Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005, 13(1):30-33.
7. Al-Lawati A.A., Venkitraman M., Al-Delaime T., Valliathu J. Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg 2002, 22(2):223-227.
8. Iturbe-Alessio I., Fonseca M.C., Mutchinik O., Santos M.A., Zajarias A., Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986, 315(22):1390-1393.
9. Vitale N., De F.M., De Santo L.S., Pollice A., Tedesco N., Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999, 33(6):1637-1641.
10. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., Nataf P., Tornos P., Torracca L., Wenink A. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28(2):230-268.
11. Bonow R.O., Carabello B.A., Chatterjee K., de Leon A.C.J., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52(13):e1-e142.
12. Born D., Martinez E.E., Almeida P.A., Santos D.V., Carvalho A.C., Moron A.F., Miyasaki C.H., Moraes S.D., Ambrose J.A. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992, 124(2):413-417.
13. Hameed A., Karaalp I.S., Tummala P.P., Wani O.R., Canetti M., Akhter M.W., Goodwin I., Zapadinsky N., Elkayam U. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001, 37(3):893-899.
14. Yinon Y., Siu S.C., Warshafsky C., Maxwell C., McLeod A., Colman J.M., Sermer M., Silversides C.K. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 2009, 104(9):1259-1263.
15. Quinn J., Von K.K., Brooks R., Peebles D., Walker F., Cohen H. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. Haematologica 2009, 94(11):1608-1612.
16. Chan W.S., Anand S., Ginsberg J.S. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000, 160(2):191-196.
17. Bodker B., Hvidman L., Weber T., Moller M., Aarre A., Nielsen K.M., Sorensen J.L. Maternal deaths in Denmark 2002-2006. Acta Obstet Gynecol Scand 2009, 88(5):556-562.
18. McLintock C., McCowan L.M., North R.A. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009, 116(12):1585-1592.
19. Sadler L., McCowan L., White H., Stewart A., Bracken M., North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000, 107(2):245-253.
20. Buss L., Tolstrup J., Munk C., Bergholt T., Ottesen B., Gronbaek M., Kjaer S.K. Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants. Acta Obstet Gynecol Scand 2006, 85(4):467-475.
21. Drenthen W., Pieper P.G., Roos-Hesselink J.W., van Lottum W.A., Voors A.A., Mulder B.J., van Dijk A.P., Vliegen H.W., Sollie K.M., Moons P., Ebels T., van Veldhuisen D.J. Pregnancy and delivery in women after Fontan palliation. Heart 2006, 92(9):1290-1294.
22. Mihaljevic T., Paul S., Leacche M., Rawn J.D., Cohn L.H., Byrne J.G. Valve replacement in women of childbearing age: influences on mother, fetus and neonate. J Heart Valve Dis 2005, 14(2):151-157.
23. Schaefer C., Hannemann D., Meister R., Elefant E., Paulus W., Vial T., Reuvers M., Robert-Gnansia E., Arnon J., De S.M., Clementi M., Rodriguez-Pinilla E., Dolivo A., Merlob P. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006, 95(6):949-957.
24. Bates S.M., Greer I.A., Hirsh J., Ginsberg J.S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 Suppl.):627S-644S.
25. Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl.):844S-886S.